Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1053/j.gastro.2010.12.044 | DOI Listing |
Front Med (Lausanne)
February 2022
Department of Gastrointestinal Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Background: Lymph node metastasis (LNM) is a critical factor in determining the prognosis of gastric cancer (GC), but its underlying mechanism remains unclear. The tumor mutational burden (TMB) has recently been recognized as a biomarker for predicting prognosis and response to immune checkpoint inhibitors, while mucin 16, cell surface associated (MUC16) is frequently mutated in GC. This study explored whether MUC16 mutation status is associated with TMB, LNM, and prognosis in patients with GC.
View Article and Find Full Text PDFGastroenterology
January 2012
Department of Internal Medicine, Division of Gastroenterology and Hepatology, Hanyang University Guri Hospital, Guri-si, Gyeonggi-do, Korea.
Gastrointest Endosc
March 2009
Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea.
BJU Int
February 2003
Breast Cancer Research Group, Department of Oncology, University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XU, Scotland, UK.
Objective: To detect the expression and transcription pattern of MUC1 in benign and malignant disease, and in two widely studied cell lines, and to investigate the glycosylation of MUC-1 in bone metastasis of prostate cancer, as mucins have been implicated in the progression and behaviour of several cancers.
Materials And Methods: RNA extracted from cell lines (DU145 and PC3), five samples of BPH and five samples of prostate cancer was reverse transcribed before amplification of MUC1-specific sequences by polymerase chain reaction. Paraffin-embedded sections were stained for glycosylated MUC1 and MUC1 core epitopes by HMFG1 and B27.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!